Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Dx Pipeline-lir 5 The DX Pipeline: OraSure Subsidiary’s DNA Test Sample Collection Kit Gets FDA Greenlight

The DX Pipeline: OraSure Subsidiary’s DNA Test Sample Collection Kit Gets FDA Greenlight

by | Feb 8, 2020 | Dx Pipeline-lir, Laboratory Industry Report

On Jan 22, Ottawa-based DNA Genotek announced that it has obtained FDA 510(k) clearance for its Oragene Dx kits for collecting saliva samples for DNA testing. According to the company, Oragene Dx is now the first and only device with general clearance for collection and stabilization of DNA from saliva for use in genetic testing […]

On Jan 22, Ottawa-based DNA Genotek announced that it has obtained FDA 510(k) clearance for its Oragene Dx kits for collecting saliva samples for DNA testing. According to the company, Oragene Dx is now the first and only device with general clearance for collection and stabilization of DNA from saliva for use in genetic testing of human germline DNA, “including prescription or over-the-counter, direct-to-consumer use.” Collected samples The kits also allow for long-term storage of samples at room temperature. DNA Genotek is a wholly-owned subsidiary of OraSure Technologies since being acquired by the latter for $50.6 million in 2011.

Other New DX Product Launches

Here’s a rundown of the other key product launches announced from late December through late January.

NEWLY LAUNCHED PRODUCTS & SERVICES
Company(ies)Product(s)/Service(s)
MGIOne Million Genomes Total Solution, software + hardware solution combining sample preparation, high-throughput sequencing + data analysis for large-scale population genome sequencing projects
Oxford Nanopore TechnologiesFlow cells using the R10.3 nanopore chemistry
CongenicaCongenica Neuro, new module for firm’s clinical decision support platform to help physicians characterize epilepsy + neurodevelopmental disorders
BioceptTarget Selector liquid biopsy assays detecting circulating tumor cells + biomarkers in cerebrospinal fluid of patients with breast or lung cancer suspected of brain or central nervous system metastases
Oxford Gene TechnologySureSeq CLL + CNV Panel for cancer research
Genome DiagnosticsNew version of NGSengine human leukocyte antigen typing software
Bio-Rad LaboratoriesSEQuoia Complete Stranded RNA Library Prep Kit for RNA-Seq library preparation
OncoCyteDetermaRx test for identifying early-stage lung cancer patients who may benefit from adjuvant chemotherapy after surgical resection
IlluminaNew sequencing platforms NextSeq 1000 + NextSeq 2000
QiagenQiaSymphony PowerFecal Pro DNA Kit for isolating microbial genomic DNA from stool + soil using QiaSymphony automation platform
Pillar BiosciencesPillar Onco/Reveal Solid Tumor Panel, a 47-gene enrichment assay for research use
PersonalisNeXT Dx Test, NGS panel to help oncologists identify potential therapies + clinical trial options for cancer patients
Viracor EurofinsViracor TRAC donor-derived, cell-free DNA assay for diagnosing kidney transplant rejection
PreventionGeneticsRapid PGxome whole-exome sequencing test
SysmexJapanese launch of Ipsogen JAK2 DX reagent
AMS BiotechnologycfPure Max kit for circulating cell-free DNA purification
Lucid Diagnostics (PAVmed subsidiary)subsidiary has launched its EsoGuard Esophageal DNA Test as
SpeeDxEuropean launch of ResistancePlus MG FleXible for GeneXpert System
Caris Life SciencesMI GPS (Genomic Profiling Similarity) Score, AI product generating tumor type biology similarity score

Subscribe to view Essential

Start a Free Trial for immediate access to this article